Chun ChenSenior Scientist, Group Lead at Amgen
Chun Chen is a Senior Scientist and a group lead of Process Development at Amgen and his responsibility is to develop drug substance processes to advance Amgen’s early stage large molecule pipeline to clinical trials. Chun has been applying quantitative and digital techniques to improve bioprocess development, including utilizing systems biology and -omics for CHO cell line development and process improvement. Chun has also worked on developing an upstream continuous manufacturing platform for process agility and intensification. Chun received his MS degree in biochemistry and molecular biology from Nanjing University, China and his PhD in genetics, bioinformatics, and computational biology from Virginia Tech.